These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36593473)

  • 41. Public versus patient health preferences: protocol for a study to elicit EQ-5D-5L health state valuations for patients who have survived a stay in intensive care.
    Halling CMB; Gudex C; Perner A; Jensen CE; Gyrd-Hansen D
    BMJ Open; 2022 May; 12(5):e058500. PubMed ID: 35613809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valuing EQ-5D-5L health states 'in context' using a discrete choice experiment.
    Cole A; Shah K; Mulhern B; Feng Y; Devlin N
    Eur J Health Econ; 2018 May; 19(4):595-605. PubMed ID: 28569351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol.
    Rowen D; Mukuria C; Bray N; Carlton J; Cooper S; Longworth L; Meads D; O'Neill C; Yang Y
    Value Health; 2023 Nov; 26(11):1625-1635. PubMed ID: 37722593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology.
    Lipman SA; Zhang L; Shah KK; Attema AE
    Eur J Health Econ; 2023 Mar; 24(2):293-305. PubMed ID: 35596831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating an EQ-5D-Y-3L Value Set for China.
    Yang Z; Jiang J; Wang P; Jin X; Wu J; Fang Y; Feng D; Xi X; Li S; Jing M; Zheng B; Huang W; Luo N
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):147-155. PubMed ID: 36396878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Valuing health-related quality of life: An EQ-5D-5L value set for England.
    Devlin NJ; Shah KK; Feng Y; Mulhern B; van Hout B
    Health Econ; 2018 Jan; 27(1):7-22. PubMed ID: 28833869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward a Smaller Design for EQ-5D-5L Valuation Studies.
    Yang Z; Luo N; Oppe M; Bonsel G; Busschbach J; Stolk E
    Value Health; 2019 Nov; 22(11):1295-1302. PubMed ID: 31708067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Valuation of the EQ-5D-3L in Russia.
    Omelyanovskiy V; Musina N; Ratushnyak S; Bezdenezhnykh T; Fediaeva V; Roudijk B; Purba FD
    Qual Life Res; 2021 Jul; 30(7):1997-2007. PubMed ID: 33713323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Latent Class Models Reveal Poor Agreement between Discrete-Choice and Time Tradeoff Preferences.
    Pullenayegum EM; Pickard AS; Xie F
    Med Decis Making; 2019 May; 39(4):421-436. PubMed ID: 30982403
    [No Abstract]   [Full Text] [Related]  

  • 50. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
    Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
    Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set.
    Jyani G; Sharma A; Prinja S; Kar SS; Trivedi M; Patro BK; Goyal A; Purba FD; Finch AP; Rajsekar K; Raman S; Stolk E; Kaur M
    Value Health; 2022 Jul; 25(7):1218-1226. PubMed ID: 35779943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EQ-5D-5L Health-State Values for the Mexican Population.
    Gutierrez-Delgado C; Galindo-Suárez RM; Cruz-Santiago C; Shah K; Papadimitropoulos M; Feng Y; Zamora B; Devlin N
    Appl Health Econ Health Policy; 2021 Nov; 19(6):905-914. PubMed ID: 34173957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ-5D-5L value functions on societal, group and individual level.
    Schneider P; Devlin N; van Hout B; Brazier J
    Health Econ; 2024 May; 33(5):894-910. PubMed ID: 38243895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review.
    Poudel N; Fahim SM; Qian J; Garza K; Chaiyakunapruk N; Ngorsuraches S
    J Med Econ; 2022; 25(1):571-582. PubMed ID: 35416095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value Set for the EQ-5D-Y-3L in Hungary.
    Rencz F; Ruzsa G; Bató A; Yang Z; Finch AP; Brodszky V
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):205-215. PubMed ID: 36123448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration.
    Finch AP; Meregaglia M; Ciani O; Roudijk B; Jommi C
    Soc Sci Med; 2022 Jan; 292():114519. PubMed ID: 34736804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
    Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
    Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How Prevalent Are Implausible EQ-5D-5L Health States and How Do They Affect Valuation? A Study Combining Quantitative and Qualitative Evidence.
    Yang Z; Feng Z; Busschbach J; Stolk E; Luo N
    Value Health; 2019 Jul; 22(7):829-836. PubMed ID: 31277831
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised comparison of online interviews versus face-to-face interviews to value health states.
    Peasgood T; Bourke M; Devlin N; Rowen D; Yang Y; Dalziel K
    Soc Sci Med; 2023 Apr; 323():115818. PubMed ID: 36940582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valuing Health State: An EQ-5D-5L Value Set for Ethiopians.
    Welie AG; Gebretekle GB; Stolk E; Mukuria C; Krahn MD; Enquoselassie F; Fenta TG
    Value Health Reg Issues; 2020 Sep; 22():7-14. PubMed ID: 31683254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.